CLINICAL_TRIALS
trial_result
· 2015-08-19
Clinical Trial Update: Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension [Phase 2]
Summary
Phase 2 trial comparing Entresto (sacubitril/valsartan) to placebo in essential hypertension evaluated efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-08-19